Editorial: Treatment and prognostic assessment of liver cirrhosis and its complications

Front Med (Lausanne). 2024 Jan 10:10:1359036. doi: 10.3389/fmed.2023.1359036. eCollection 2023.

Feifei Lu^#^{1

2}, Thierry Thévenot^#³, Andrea Mancuso^#⁴, Yiling Li^#⁵, Lei Liu^#⁶, Xingshun Qi^{1

2}

¹ College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
² Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
³ Department of Hepatology, University Hospital of Besançon, Besançon, France.
⁴ Dipartimento di Medicina Interna, ARNAS Ospedali Civico Di Cristina Benfratelli, Palermo, Italy.
⁵ Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, China.
⁶ State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.

^# Contributed equally.

No abstract available

Keywords: complications; liver cirrhosis; pathogenesis; prognosis; risk factor; treatment.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.